Trial intelligence / Profile preview

Ivabradine versus metoprolol before coronary computed tomography angiography

ISRCTN74875961Phase 4Completed

Sponsor
Medical University of Vienna
Start
Mar 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in coronary arteriosclerosis comparing Ivabradine with Metoprolol (2 arms). Primary endpoint: Heart rate reduction. Started Mar 2007; status: completed.

02

Drugs

ivabradinemetoprolol
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on ISRCTN74875961.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN74875961.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call